|
FOXO3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.407600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.252200E-02 |
| Normal-vs-Stage2 |
8.836000E-01 |
| Normal-vs-Stage3 |
4.191600E-01 |
| Normal-vs-Stage4 |
1.775790E-01 |
| Stage1-vs-Stage2 |
1.159040E-01 |
| Stage1-vs-Stage3 |
2.577100E-03 |
| Stage1-vs-Stage4 |
1.338760E-03 |
| Stage2-vs-Stage3 |
6.801200E-01 |
| Stage2-vs-Stage4 |
3.937600E-01 |
| Stage3-vs-Stage4 |
5.298600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.877600E-01 |
| Normal-vs-AfricanAmerican |
6.553000E-01 |
| Normal-vs-Asian |
7.665800E-01 |
| Caucasian-vs-AfricanAmerican |
9.977000E-01 |
| Caucasian-vs-Asian |
9.244400E-01 |
| AfricanAmerican-vs-Asian |
9.297800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.510400E-01 |
| Normal-vs-Female |
2.269600E-01 |
| Male-vs-Female |
4.917800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.778800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.334000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.956600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.858200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.389600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.923600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.010400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.029600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.406180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.655000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.600600E-03 |
| Normal-vs-Grade 2 |
2.997800E-03 |
| Normal-vs-Grade 3 |
3.788200E-01 |
| Normal-vs-Grade 4 |
4.950400E-02 |
| Grade 1-vs-Grade 2 |
1.995940E-02 |
| Grade 1-vs-Grade 3 |
1.351980E-04 |
| Grade 1-vs-Grade 4 |
3.61589999999801E-05 |
| Grade 2-vs-Grade 3 |
2.391300E-04 |
| Grade 2-vs-Grade 4 |
1.550370E-04 |
| Grade 3-vs-Grade 4 |
2.105200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.27959999999206E-05 |
| Normal-vs-ccB subtype |
8.238400E-02 |
| ccA subtype-vs-ccB subtype |
4.67840000073494E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.720200E-01 |
| Normal-vs-N1 |
1.880150E-02 |
| N0-vs-N1 |
6.363700E-02 |
|
|
